CG Oncology (CGON) Capital Expenditures (2024 - 2026)
CG Oncology (CGON) posted Capital Expenditures of $304000.0 for Q1 2026, up 4242.86% on a QoQ basis from $7000.0 in Q4 2025, and up 1800.0% year-over-year from $16000.0 in Q1 2025.
CG Oncology (CGON) Capital Expenditures (2024 - 2026) Analysis & Trends
CG Oncology's Capital Expenditures history runs 3 years deep, the most recent figure standing at $304000.0 for Q1 2026.
- Quarterly Capital Expenditures rose 1800.0% year-over-year to $304000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $422000.0 (up 77.31% YoY) and the FY2025 annual result came in at $134000.0, down 42.74% from the prior year.
- Capital Expenditures was $304000.0 for Q1 2026 at CG Oncology, up from $7000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $304000.0 in Q1 2026 and bottomed at -$1000.0 in Q3 2024.
- A 3-year average of $74666.7 and a median of $14000.0 in 2024 frame the typical range for Capital Expenditures.
- Peak annual rise in Capital Expenditures reached 9800.0% in 2025, while the deepest fall reached 96.65% in 2025.
- CG Oncology's Capital Expenditures stood at $209000.0 in 2024, then sank by 96.65% to $7000.0 in 2025, then soared by 4242.86% to $304000.0 in 2026.
- Business Quant data shows CGON's Capital Expenditures at $304000.0 in Q1 2026, $7000.0 in Q4 2025, and $97000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | CG Oncology | 6.01 Bn | 6.01 Bn | -1.88 Mn | 304,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 304,000.00 |
| Mar 31, 2026 | 304,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Dec 31, 2025 | 7,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Sep 30, 2025 | 97,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Jun 30, 2025 | 14,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Mar 31, 2025 | 16,000.00 |
| Dec 31, 2024 | 209,000.00 |
| Dec 31, 2024 | 209,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 14,000.00 |
| Mar 31, 2024 | 12,000.00 |
| Mar 31, 2024 | 12,000.00 |